4.4 Article

γ-Glutamyltranspeptidase as a Prognostic Biomarker in Advanced Hepatocellular Carcinoma Treated with Transarterial Chemoembolization

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

Masao Omata et al.

HEPATOLOGY INTERNATIONAL (2017)

Review Biotechnology & Applied Microbiology

Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk

Gerald Koenig et al.

DISEASE MARKERS (2015)

Article Gastroenterology & Hepatology

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

et al.

JOURNAL OF HEPATOLOGY (2015)

Editorial Material Gastroenterology & Hepatology

Management of Hepatocellular Carcinoma: An Update

Jordi Bruix et al.

HEPATOLOGY (2011)

Article Gastroenterology & Hepatology

Elevated Serum Alanine Aminotransferase and γ-Glutamyltransferase and Mortality in the United States Population

Constance E. Ruhl et al.

GASTROENTEROLOGY (2009)

Article Oncology

Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women

Alexander M. Strasak et al.

INTERNATIONAL JOURNAL OF CANCER (2008)

Review Pharmacology & Pharmacy

γ-Glutamyltransferase, redox regulation and cancer drug resistance

Alfonso Pompella et al.

CURRENT OPINION IN PHARMACOLOGY (2007)

Article Urology & Nephrology

Serum gamma glutamyl-transferase is a sensitive but unspecific marker of metastatic renal cell carcinoma

Tatjana Simic et al.

INTERNATIONAL JOURNAL OF UROLOGY (2007)

Article Gastroenterology & Hepatology

Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan

Iwao Ikai et al.

HEPATOLOGY RESEARCH (2007)

Review Medical Laboratory Technology

Analysis of glutathione: implication in redox and detoxification

A Pastore et al.

CLINICA CHIMICA ACTA (2003)